ACE2 decoy Fc-fusions and bispecific killer engagers require Fc engagement for in vivo efficacy against SARS-CoV-2. (academic.oup.com)

Authors: Dick JK … Hart GT Journal: Journal of Immunology Published: 2026-08-04 DOI: https://doi.org/10.1093/jimmun/vkag235